Weiss Multi-Strategy Advisers’s TherapeuticsMD TXMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,328
Closed -$59K 794
2021
Q4
$59K Sell
3,328
-403
-11% -$12.1K ﹤0.01% 631
2021
Q3
$138K Buy
3,731
+64
+2% +$2.84K ﹤0.01% 648
2021
Q2
$218K Buy
3,667
+131
+4% +$7.94K ﹤0.01% 615
2021
Q1
$237K Buy
3,536
+516
+17% +$40.4K 0.01% 631
2020
Q4
$183K Sell
3,020
-100
-3% -$6.83K ﹤0.01% 654
2020
Q3
$246K Buy
3,120
+34
+1% +$2.71K 0.01% 523
2020
Q2
$193K Buy
3,086
+106
+4% +$6.17K 0.01% 521
2020
Q1
$158K Sell
2,980
-110
-4% -$10.9K 0.01% 393
2019
Q4
$374K Buy
3,090
+170
+6% +$24.4K 0.01% 549
2019
Q3
$530K Buy
2,920
+220
+8% +$31K 0.01% 487
2019
Q2
$351K Buy
2,700
+1,700
+170% +$305K 0.01% 445
2019
Q1
$244K Buy
1,000
+700
+233% +$185K 0.01% 470
2018
Q4
$57K Buy
+300
New +$73.2K ﹤0.01% 433
2016
Q4
Sell
-620
Closed -$211K 518
2016
Q3
$211K Sell
620
-7
-1% -$2.56K 0.01% 396
2016
Q2
$266K Sell
627
-554
-47% -$228K 0.02% 359
2016
Q1
$378K Buy
1,181
+881
+294% +$301K 0.02% 402
2015
Q4
$156K Sell
300
-200
-40% -$73.8K 0.01% 355
2015
Q3
$147K Buy
+500
New +$178K 0.01% 372

Other funds holding TXMD

Weiss Multi-Strategy Advisers's TXMD Position: Q1 2022 in Review

Weiss Multi-Strategy Advisers sold out of TherapeuticsMD (TXMD) in Q1 2022, closing a stake of 3,328 shares — an estimated $59K sold.

Weiss Multi-Strategy Advisers first reported a position in TXMD in Q3 2015 and held it in 18 quarters. The position peaked at $530K in Q3 2019. 124 funds tracked by Wall St. Rank hold TXMD as of Q1 2022.

  • Weiss Multi-Strategy Advisers reported no remaining TherapeuticsMD position as of Q1 2022 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 3,328 TherapeuticsMD shares in Q1 2022, an estimated $59K.
  • Weiss Multi-Strategy Advisers first reported a position in TherapeuticsMD in Q3 2015 and held it in 18 quarters.
  • Weiss Multi-Strategy Advisers's TherapeuticsMD position peaked at $530K in Q3 2019.
  • 124 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2022.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2022, filed 16 May 2022.